The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecules

Vista senzilla d'ítem
dc.contributor.authorde la Torre, Beatriz G.
dc.contributor.authorAlbericio Palomera, Fernando
dc.date.accessioned2020-05-06T15:29:41Z
dc.date.available2020-05-06T15:29:41Z
dc.date.issued2017-02-27
dc.date.updated2020-05-06T15:29:42Z
dc.description.abstractThis is an analysis from a chemical point of view of the 22 drugs accepted by the FDA during 2016. The different drugs from the 2016 "harvest" have been classified according to their chemical structure: antibodies; TIDES (oligonucleotides and peptides); amino acids and natural products; drug combination; and small molecules.
dc.format.extent6 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec681089
dc.identifier.issn1420-3049
dc.identifier.pmid28264468
dc.identifier.urihttps://hdl.handle.net/2445/158950
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/molecules22030368
dc.relation.ispartofMolecules, 2017, vol. 22, num. 3, p. 368
dc.relation.urihttps://doi.org/10.3390/molecules22030368
dc.rightscc-by (c) de la Torre, Beatriz G. et al., 2017
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Química Inorgànica i Orgànica)
dc.subject.classificationDisseny de medicaments
dc.subject.classificationPèptids
dc.subject.classificationFarmacologia
dc.subject.otherDrug design
dc.subject.otherPeptides
dc.subject.otherPharmacology
dc.titleThe Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecules
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Miniatura
Nom:
681089.pdf
Mida:
1.42 MB
Format:
Adobe Portable Document Format
Descarregar

Col·leccions

Articles publicats en revistes (Química Inorgànica i Orgànica)